Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis

US9700562B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · US

Inventors

• Richard J. Sciotti · Saline, US
• Gregory A. Reichard · Lovettsville, US
• Kristina M. Pannone · Columbia, US
• Victor E. Zottig · Bethesda, US

Key dates

• Filing date: Apr 5, 2016
• Grant date: Jul 11, 2017
• Expiry date: Apr 5, 2036

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein are triazine compounds and methods of making and using thereof to treat malaria, provide chemoprophylaxis, and/or treat or inhibit infection by one or more Plasmodium spp.